Nina Sanford, M.D., Chief of Gastrointestinal Radiation Oncology Service
Gastrointestinal Cancer
New Patient Appointment or 214-645-8525
UT Southwestern Medical Center’s gastrointestinal cancer program includes a dedicated team that offers a level of expertise unmatched in Dallas and North Texas. We provide our patients with comprehensive, timely, and effective care.
Our GI team uses the latest techniques with the most modern approaches, such as 3-D conformal radiotherapy, intensity-modulated radiation therapy (IMRT), and brachytherapy implants.
Meet Our Team
Todd Aguilera, M.D., Ph.D.
Shahed Badiyan, M.D.
Amy Sessions, M.P.A.S., PA-C
Andrew Wang, M.D.
Multidisciplinary Team Approach to Pancreatic Cancer
Learn about UT Southwestern's multidisciplinary approach to the treatment of pancreatic cancer.
Gastrointestinal Clinical Trials
As one of the top academic medical centers in the country and the only National Cancer Institute-designated cancer center in North Texas, we lead and participate in a number of clinical trials aimed at improving the outcomes of patients with cancer. The Department of Radiation Oncology enrolls approximately 200 new patients in clinical trials each year.
Clinical trials are critical in developing new therapies for cancer and can mean having access to new medication, groundbreaking research, and additional clinical care. Our clinical trials team is comprised of radiation oncologists, radiation biologists, clinical research coordinators, quality assurance coordinators, and clinical data specialists.
STU 2024-0601 (ULTRAS) Ultra-High-Dose Radiation for Liver Metastasis Using MR-Guided Treatment with Stereotactic Ablative Single-Fraction (ULTRAS): Phase III Randomized Controlled Trial.
STU 2024.0475 (Morpheus) A Phase III Study Testing Two Dose Escalation Strategies to Increase the Population of Complete Responders After Radiation Therapy in the Context of Organ Preservation for Patients With Rectal Cancer.
STU 20252048 (NRG-GI011) A Phase III Randomized Trial of Dose-Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100).
STU20260105 (EXPAND) EXtending Outcomes for PAncreas Cancer Patients with Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial.
If you’re interested in a clinical trial, please talk to your doctor.
Learn more about clinical trials.
Helpful Resources
Our patients share their stories and experiences within the Department of Radiation Oncology at UT Southwestern.
Radiation therapy can sound frightening, but we’re here to guide patients throughout their journey. From our dedicated team of physicians and therapists to dietitians and social services, we can help with any questions or concerns.
We offer a variety of support services to help those with cancer and their families.